Christopher B. Ford
Christopher B. Ford
Senior Director, Seres Therapeutics
Verified email at serestherapeutics.com
Title
Cited by
Cited by
Year
Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection
CB Ford, PL Lin, MR Chase, RR Shah, O Iartchouk, J Galagan, ...
Nature genetics 43 (5), 482-486, 2011
4002011
Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis
CB Ford, RR Shah, MK Maeda, S Gagneux, MB Murray, T Cohen, ...
Nature genetics 45 (7), 784-790, 2013
3362013
Sterilization of granulomas is common in active and latent tuberculosis despite within-host variability in bacterial killing
PL Lin, CB Ford, MT Coleman, AJ Myers, R Gawande, T Ioerger, ...
Nature medicine 20 (1), 75-79, 2014
3322014
The evolution of drug resistance in clinical isolates of Candida albicans
CB Ford, JM Funt, D Abbey, L Issi, C Guiducci, DA Martinez, T Delorey, ...
Elife 4, e00662, 2015
1792015
Magnetic barcode assay for genetic detection of pathogens
M Liong, AN Hoang, J Chung, N Gural, CB Ford, C Min, RR Shah, ...
Nature communications 4 (1), 1-9, 2013
1322013
Mycobacterium tuberculosis–heterogeneity revealed through whole genome sequencing
C Ford, K Yusim, T Ioerger, S Feng, M Chase, M Greene, B Korber, ...
Tuberculosis 92 (3), 194-201, 2012
882012
Expression of the Helicobacter pylori adhesin SabA is controlled via phase variation and the ArsRS signal transduction system
AC Goodwin, DM Weinberger, CB Ford, JC Nelson, JD Snider, JD Hall, ...
Microbiology 154 (Pt 8), 2231, 2008
812008
Computational Modeling Predicts IL-10 Control of Lesion Sterilization by Balancing Early Host Immunity–Mediated Antimicrobial Responses with Caseation during Mycobacterium …
NA Cilfone, CB Ford, S Marino, JT Mattila, HP Gideon, JAL Flynn, ...
The Journal of Immunology 194 (2), 664-677, 2015
592015
DNA replication fidelity in Mycobacterium tuberculosis is mediated by an ancestral prokaryotic proofreader
JM Rock, UF Lang, MR Chase, CB Ford, ER Gerrick, R Gawande, ...
Nature genetics 47 (6), 677-681, 2015
462015
Distinct effects on diversifying selection by two mechanisms of immunity against Streptococcus pneumoniae
Y Li, T Gierahn, CM Thompson, K Trzciński, CB Ford, N Croucher, ...
PLoS Pathog 8 (11), e1002989, 2012
422012
Rifampin resistance mutations are associated with broad chemical remodeling of Mycobacterium tuberculosis
N Lahiri, RR Shah, E Layre, D Young, C Ford, MB Murray, SM Fortune, ...
Journal of Biological Chemistry 291 (27), 14248-14256, 2016
372016
The mutation rate of mycobacterial repetitive unit loci in strains of M. tuberculosis from cynomolgus macaque infection
MN Ragheb, CB Ford, MR Chase, PL Lin, JAL Flynn, SM Fortune
BMC genomics 14 (1), 145, 2013
262013
Coordinated host-pathogen transcriptional dynamics revealed using sorted subpopulations and single macrophages infected with Candida albicans
JF Muņoz, T Delorey, CB Ford, BY Li, DA Thompson, RP Rao, CA Cuomo
Nature communications 10 (1), 1-15, 2019
142019
Fecal microbiota transplantation for the improvement of metabolism in obesity: The FMT-TRIM double-blind placebo-controlled pilot trial
EW Yu, L Gao, P Stastka, MC Cheney, J Mahabamunuge, M Torres Soto, ...
PLoS medicine 17 (3), e1003051, 2020
92020
Transcriptional heterogeneity of Cryptococcus gattii VGII compared with non-VGII lineages underpins key pathogenicity pathways
RA Farrer, CB Ford, J Rhodes, T Delorey, RC May, MC Fisher, ...
Msphere 3 (5), 2018
62018
SER-109, an Investigational Microbiome Drug to Reduce Recurrence after Clostridioides difficile infection: Lessons Learned from a Phase 2 Trial
BH McGovern, CB Ford, MR Henn, DS Pardi, S Khanna, EL Hohmann, ...
Clinical Infectious Diseases, 2020
42020
Coordinated host-pathogen transcriptional dynamics revealed using sorted subpopulations and single, Candida albicans infected macrophages
JF Muņoz, T Delorey, CB Ford, BY Li, DA Thompson, RP Rao, CA Cuomo
BioRxiv, 350322, 2019
42019
1641. Treatment of Recurrent Clostridium difficile Infection With SER-109 Reduces Gastrointestinal Carriage of Antimicrobial Resistance Genes
C Ford, M Henn, J Bryant, L Diao, J Wortman, A Tomlinson, K Litcofsky, ...
Open Forum Infectious Diseases 5 (suppl_1), S46-S47, 2018
32018
Transcriptional Heterogeneity of Cryptococcus gattii VGII Compared with Non-VGII Lineages Underpins Key Pathogenicity Pathways. mSphere 3
RA Farrer, CB Ford, J Rhodes, T Delorey, RC May, MC Fisher, ...
32018
621. Treatment of Recurrent Clostridium difficile Infection with SER-109 Increases the Concentration of Secondary Bile Acids in a Dose-Dependent Manner
M Henn, C Ford, E O’Brien, J Wortman, L Diao, C Desjardins, ...
Open Forum Infectious Diseases 5 (suppl_1), S226-S227, 2018
22018
The system can't perform the operation now. Try again later.
Articles 1–20